Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort.

Abstact

No abstract available.

Authors
  • (None specified)
PubMed ID
Appears In